NCT05662930 is a clinical trial of First arithmetic problem solving in Diabetes, sponsored by Istanbul University.

Who is sponsoring NCT05662930?

NCT05662930 is sponsored by Istanbul University.

What drugs are being tested in NCT05662930?

Interventions in NCT05662930: First arithmetic problem solving, Second arithmetic problem solving, Third arithmetic problem solving, Fourth arithmetic problem solving, Fifth arithmetic problem solving, Sixth arithmetic problem solving.

What condition does NCT05662930 study?

NCT05662930 studies Diabetes, Hypertension.

Is NCT05662930 still recruiting?

NCT05662930 is currently completed. Last updated 23 December 2022.

Last reviewed 2022-12-23 · How we verify

NCT05662930

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation Of Stress Response In Diabetic Hypertensive Patients

Completed Last updated 23 December 2022

What this trial tests

trial testing First arithmetic problem solving in Diabetes in 62 participants. Completed in 4 September 2018.

Timeline

1 June 2016

Primary endpoint
30 November 2017

4 September 2018

Quick facts

Lead sponsor	Istanbul University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	62
Start date	1 June 2016
Primary completion	30 November 2017
Estimated completion	4 September 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

First arithmetic problem solving
Second arithmetic problem solving
Third arithmetic problem solving
Fourth arithmetic problem solving
Fifth arithmetic problem solving
Sixth arithmetic problem solving

Conditions studied

Diabetes — all drugs for Diabetes →
Hypertension — all drugs for Hypertension →

Sponsor

Istanbul University

Who can join

Adults 40 to 65, male only, with Diabetes or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this research, we aimed to examine salivary cortisol changes in the cognitive stress response of patients with Hypertension + Diabetes Mellitus (HT+DM) and Hypertension (HT) and to determine the differences between them. The research was conducted by solving an arithmetic task as a stress test in 62 patients with HT+DM and HT that are being treated in the outpatient clinic of Medical Pharmacology and Clinical Pharmacology Department at Istanbul University, Istanbul Medical Faculty Hospital.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluation of Stress Response in Middle-Aged Male Diabetic Hypertensive Patients.
Alloqi Tahirbegolli I, Tahirbegolli B, Şen S, Sayın B, et al · · 2023 · cited 1× · PMID 36880261 · DOI 10.1210/clinem/dgad122

Verify or expand the search:

Other recruiting trials for Diabetes

Currently open trials in the same condition.

NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07417865 — ECHO Diabetes FQHC · recruiting

Other Istanbul University trials

Trials by the same sponsor.

NCT07472946 — Whole-Body Vibration Exercise in Patients With Parkinson's Disease · NA · not yet recruiting
NCT07433894 — Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic Arthritis · not yet recruiting
NCT07420049 — Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study · not yet recruiting
NCT07415967 — The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain · NA · recruiting
NCT07473024 — pEEG-Guided Anesthesia and Behavioral Outcomes in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05662930 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul University
Last refreshed: 23 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05662930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing